Sitemap > Breaking Research > GenitoUrinary Tract Disorders
Displaying 151 - 200 of 759 results
- Major depression in female urinary incontinence.
- Phosphodiesterase 5 inhibitor ameliorates renal resistance to atrial natriuretic peptide associated with obesity and hyperleptinemia.
- Sildenafil in the treatment of antipsychotic-induced erectile dysfunction: a randomized, double-blind, placebo-controlled, flexible-dose, two-way crossover trial.
- The cannabinoid CB1 receptor antagonist SR 141716A induces penile erection by increasing extra-cellular glutamic acid in the paraventricular nucleus of male rats.
- Effect of an ATP-sensitive potassium channel opener in subjects with overactive bladder: a randomized, double-blind, placebo-controlled study (ZD0947IL/0004).
- Treatment with anti-TNF monoclonal antibody (c5N) reduces the extent of induced endometriosis in the baboon.
- Voltage-dependent Ca2+-channel block by openers of intermediate and small conductance Ca2+-activated K+ channels in urinary bladder smooth muscle cells.
- [Alpha1-adrenoceptor subtypes and alpha1-adrenoceptor antagonists]
- [Alpha1-adrenoceptor subtype selectivity and organ specificity of silodosin (KMD-3213)]
- [Effects of silodosin (KMD-3213) on phenylephrine-induced increase in intraurethral pressure and blood pressure in rats--study of the selectivity for lower urinary tract]
- [Effect of silodosin on intraurethral pressure increase induced by hypogastric nerve stimulation in dogs with benign prostatic hyperplasia]
- [Duration of action of silodosin (KMD-3213) against phenylephrine-induced increase in intraurethral pressure in rats]
- JNJ-10280205 and JNJ-10287069: Novel PDE5 inhibitors as clinical candidates for erectile dysfunction.
- Safety and tolerability of duloxetine in women with stress urinary incontinence.
- Effects of tamsulosin on resting urethral pressure and arterial blood pressure in anaesthetized female dogs.
- Safety and efficacy of tamsulosin in the treatment of painful ejaculation: a randomized, double-blind, placebo-controlled study.
- Circulating endothelial progenitor cells and endothelial function after chronic Tadalafil treatment in subjects with erectile dysfunction.
- Safety and efficacy of tramadol in the treatment of idiopathic detrusor overactivity: a double-blind, placebo-controlled, randomized study.
- An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
- SV2 is the protein receptor for botulinum neurotoxin A.
- The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS).
- How frequent are invasive therapies required in patients receiving tamsulosin for benign prostatic hyperplasia? A retrospective long-term study.
- Treatment strategy for "non-responders" to tadalafil and vardenafil: a real-life study.
- Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey.
- Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial.
- The potential and promise of using botulinum toxin in the prostate gland.
- Development of a "reverse capture" autoantibody microarray for studies of antigen-autoantibody profiling.
- Molecular properties and preclinical pharmacology of JNJ-1250132, a steroidal progesterone receptor modulator that inhibits binding of the receptor to DNA in vitro.
- Selective beta-adrenoceptor agonists, calcium antagonists and potassium channel openers as a possible medical treatment of the overactive bladder and urge incontinence.
- Characterization of intracavernous pressure increase induced by Ym348, a novel 5-HT2C receptor agonist, in anesthetized rats.
- Inhibitory effects of L- and T-type calcium antagonists on contractions of human detrusor muscle.
- BPH: epidemiology and comorbidities.
- Treatment and pharmacologic management of BPH in the context of common comorbidities.
- BPH: costs and treatment outcomes.
- Pharmacological management of women with mixed urinary incontinence.
- Salvage of sildenafil failures with cabergoline: a randomized, double-blind, placebo-controlled study.
- Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence.
- Effects of streptozotocin-induced diabetes on bladder and erectile (dys)function in the same rat in vivo.
- The calpain inhibitor, A-705253, corrects penile nitrergic nerve dysfunction in diabetic mice.
- 5-Alkylated thiazolidinones as follicle-stimulating hormone (FSH) receptor agonists.
- Efficacy and safety of tadalafil across ethnic groups and various risk factors in men with erectile dysfunction: Use of a novel noninferiority study design.
- Tolerance to the therapeutic effect of tadalafil does not occur during 6 months of treatment: A randomized, double-blind, placebo-controlled study in men with erectile dysfunction.
- Efficacy and safety of two dosing regimens of tadalafil and patterns of sexual activity in men with diabetes mellitus and erectile dysfunction: Scheduled use vs. on-demand regimen evaluation (SURE) study in 14 European countries.
- Sildenafil citrate improves self-esteem, confidence, and relationships in men with erectile dysfunction: Results from an international, multi-center, double-blind, placebo-controlled trial.
- Urinary incontinence after radical prostatectomy: incidence by definition, risk factors and temporal trend in a large series with a long-term follow-up.
- A novel approach to the treatment of benign prostatic hyperplasia.
- Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence.
- Efficacy and tolerability of tolterodine extended-release in continent patients with overactive bladder and nocturia.
- Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity.
- Effect of doxazosin with and without rho-kinase inhibitor on human corpus cavernosum smooth muscle in the presence of bladder outlet obstruction.